Tenax Therapeutics, Inc. (TENX)
16.05
+0.15
(+0.94%)
USD |
NASDAQ |
Jan 16, 16:00
16.00
-0.05
(-0.31%)
After-Hours: 04:14
Tenax Therapeutics EPS Diluted (Quarterly): -0.3977 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| CEL-SCI Corp. | -0.7611 |
| AIM ImmunoTech, Inc. | -1.567 |
| IGC Pharma, Inc. | -0.0201 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Protalix Biotherapeutics, Inc. | 0.0291 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -15.80M |
| Total Expenses (Quarterly) | 15.80M |
| Enterprise Value | 0.8408M |
| Earnings Yield | -7.06% |
| Normalized Earnings Yield | -7.065 |